Reduction of NT-proBNP in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction in short-term treatment with empagliflozin on top of existing therapy
27 May 2019 (08:30 - 18:00)
Organised by:
Abstract
Slides
About the speaker
Specialized Hospital for Active Treatment in Cardiology Cardiolife, Varna (Bulgaria)
56 More presentations in this session
Access the full session
The Event
Heart Failure 2019
27 May 2019
08:30 CET
You may be interested in
Congress Presentation
